Loading...
•
Dec 31, 2025
Enhabit Q4 2025 Earnings Report
Enhabit reported higher revenue and adjusted EBITDA in Q4 2025 driven by growth in home health and hospice patient census, though the company recorded a net loss due to impairment charges.
Key Takeaways
Enhabit generated $270400000 in net service revenue in Q4 2025, supported by growth in both home health and hospice segments. Adjusted EBITDA increased to $28000000, while the company reported a net loss of $38700000 primarily due to goodwill impairment charges.
Total net service revenue increased to $270400000 with growth across home health and hospice segments.
Adjusted EBITDA reached $28000000 with a margin of 10.4%.
Home health revenue totaled $206800000 while hospice revenue reached $63600000.
Net loss attributable to Enhabit was $38700000 due largely to impairment charges.
Revenue by Segment
Forward Guidance
The company suspended forward financial guidance due to the pending acquisition by Kinderhook Industries expected to close in the second quarter of 2026.
Positive Outlook
- Continued growth in patient census across home health and hospice segments.
- Adjusted EBITDA increased year-over-year demonstrating operational improvement.
- Improved free cash flow and continued debt reduction.
- Expansion through new de novo locations.
- Strong strategic positioning ahead of proposed acquisition.
Challenges Ahead
- Pending acquisition introduces uncertainty until transaction completion.
- Net loss driven by impairment charges and restructuring costs.
- Medicare admissions declined year-over-year.
- Revenue per episode declined compared to the prior year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...